Inventaire - your friends and communities are your best library

The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease

author

Ditte S Jonesco

published in: Frontiers in Neurology

date of publication: 2015

language: English

main subject: biomarker, Alzheimer's disease, dementia

Cites articles 199

Date

Title

Authors

2015-06-01

APOEε2 is associated with milder clinical and pathological Alzheimer disease

Bradley Hyman, Rebecca Betensky, Sarah E Monsell, ALBERTO SERRANO-POZO
2015-01-13

Plasma levels of apolipoprotein E and risk of dementia in the general population

Børge G. Nordestgaard, Anne Tybjærg-Hansen, Ruth Frikke-Schmidt, Katrine W Rasmussen
2015-01-26

Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players.

Yelverton Tegner, Henrik Zetterberg, Kaj Blennow
2015-01-01

Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies

Jacopo C. DiFrancesco, Giorgio B Boncoraglio, Fabrizio Piazza, Fabrizio Tagliavini, Giorgio Giaccone, Laura Farina, Mario Savoiardo
2015-01-01

Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's disease

Agustín Ruíz
2015-01-01

Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.
2014-05-07

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Elisabet Londos, Lennart Minthon, Katarina Nägga, Sara Hall
2014-03-27

Extracellular proteolysis of apolipoprotein E (apoE) by secreted serine neuronal protease
2014-01-16

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

Paolo Eusebi, Silvia Paciotti, Laura Bonanni, Marco Onofrj, Lucilla Parnetti, Davide Chiasserini, Paolo Calabresi, Emanuele Persichetti, Aroldo Rossi, Shiji Varghese, Andrea Dardis, Nicola Tambasco, Bruno Bembi
2014-01-01

Developing novel blood-based biomarkers for Alzheimer's disease

Maria C Carrillo, Simon Lovestone, Michelle M Mielke, Sid O'Bryant, Magnus Sjögren, Jessica L. Teeling, Malcolm A Ward, Tim West, Francine Grodstein, Eugenia Trushina, Heather M Snyder
2014-04-08

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Oskar Hansson, Dag Aarsland, Marinus Blankenstein, Sanna-Kaisa Herukka, Mony J de Leon, Wiesje van der Flier, Philip Scheltens, Harald Hampel, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Charlotte Teunissen, Magda N. Tsolaki, Niklas Mattsson, Lucilla Parnetti, Femke Bouwman, Pieter Jelle Visser, Georg Christian Oeder, Jan Marcusson, Marcel G M Olde Rikkert
2014-01-15

Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels.

Eugeen Vanmechelen, Sebastiaan Engelborghs, Manu Vandijck, Peter Paul De Deyn, Jean-Jacques Martin, Sylvie Slaets, Nathalie Le Bastard
2014-01-16

Reduced cellular Ca(2+) availability enhances TDP-43 cleavage by apoptotic caspases

Giovanni DeMarco, Cristina Ramondetti, Cristina Moglia, Francesco Novelli, Adriano Chiò, Andrea Calvo, Michael Mostert
2013-02

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

David S Knopman, Ronald C. Petersen, Prashanthi Vemuri, Heather J Wiste, Stephen Weigand, John Q. Trojanowski, Paul S. Aisen, Nathan Pankratz
2013-10-23

Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
2013-10-29

The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2.

Verena Heise, Clare E. Mackay
2013-10-22

Blood-brain-barriers in aging and in Alzheimer's disease

João Carlos Sousa, Fernanda Marques, Joana Almeida Palha, Nuno Sousa
2013-10-07

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

Henrik Zetterberg, Kaj Blennow, Erik Portelius
2013-11-19

Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation
2013-07-23

Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis

Inga Zerr
2013-07-11

The future of blood-based biomarkers for Alzheimer's disease

Sid O'Bryant, Simon Lovestone, Michael W. Weiner, Harald Hampel, Kaj Blennow, John Q. Trojanowski, William Hu, Magnus Sjögren, Tony Wyss-Coray, Holly D Soares, Andreas Jeromin, Chantal Bazenet, Thomas J Montine
2013-06-21

Fluid biomarkers in Alzheimer's disease - current concepts

Oskar Hansson, Henrik Zetterberg, Kaj Blennow
2013-06-01

Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission

Nicole Leclerc
2013-05-22

An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function
2013-06-01

Tau pathology and neurodegeneration

Maria Grazia Spillantini
2013-04-23

Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases
2013-04-26

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies

Giorgio Giaccone, Carlo Ferrarese
2013-03-28

Plasma tau levels in Alzheimer's disease

Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Ulf Andreasson
2013-01-08

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

Oskar Hansson, Lennart Minthon
2013-10-15

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease

Ming-Jang Chiu, Jen-Jie Chieh, Kai-Yuan Tzen
2013-09-06

Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load.

Markus Glatzel, Alvaro A Barrera-Ocampo, Diego Sepulveda-Falla, Jakob Matschke
2013-08-24

High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.

Inga Liepelt-Scarfone, Christina Unger Lithner, Taher Darreh-Shori, Daniela Berg, Walter Maetzler

Article - wd:Q26853347

Welcome to Inventaire

the library of your friends and communities

learn more